Bragar Eagel & Squire, P.C. Reminds Stockholders of aTyr, Marex, Cepton, and MoonLake to Contact the Firm About their Rights Before Upcoming Deadlines - aTyr Pharma ( NASDAQ:ATYR )
NEW YORK, Nov. 17, 2025 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of aTyr Pharma, Inc. ( NASDAQ:ATYR ) , Marex Group PLC ( NASDAQ:MRX ) , Cepton, Inc. ...
Investors who lost money on aTyr Pharma, Inc. ( ATYR ) should contact Levi & Korsinsky about pending Class Action - ATYR - aTyr Pharma ( NASDAQ:ATYR )
NEW YORK, Nov. 17, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in aTyr Pharma, Inc. ( "aTyr" or the "Company" ) ( NASDAQ:ATYR ) of a class action securities lawsuit.
aTyr Pharma, Inc. ( ATYR ) Failed Drug Trial Spurs Securities Lawsuit; Class Period Significantly Enlarged - Hagens Berman - aTyr Pharma ( NASDAQ:ATYR )
SAN FRANCISCO, Nov. 17, 2025 ( GLOBE NEWSWIRE ) -- A new class action complaint has been filed against aTyr Pharma, Inc. ( NASDAQ:ATYR ) and certain of its top executives, significantly enlarging the alleged class period covered by the ongoing securities litigation.
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ...
aTyr Pharma, Inc. Class Action: Levi & Korsinsky Reminds aTyr Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 8, 2025 - ATYR - aTyr Pharma ( NASDAQ:ATYR )
NEW YORK, Nov. 14, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in aTyr Pharma, Inc. ( "aTyr" or the "Company" ) ( NASDAQ:ATYR ) of a class action securities lawsuit.
ATYR SHAREHOLDER ALERT: New aTyr Pharma, Inc. ( ATYR ) Securities Class Filed; Class Period Significantly Enlarged -- Hagens Berman - aTyr Pharma ( NASDAQ:ATYR )
SAN FRANCISCO, Nov. 14, 2025 ( GLOBE NEWSWIRE ) -- A new class action complaint has been filed against aTyr Pharma, Inc. ( NASDAQ:ATYR ) and certain of its top executives, significantly enlarging the alleged class period covered by the ongoing securities litigation.
ATYR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that aTyr Pharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - aTyr Pharma ( NASDAQ:ATYR )
NEW YORK, Nov. 14, 2025 ( GLOBE NEWSWIRE ) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against aTyr Pharma, Inc. ( "aTyr" or "the Company" ) ( NASDAQ:ATYR ) and certain of its ...
DEADLINE ALERT for ATYR, MLTX, BAX, JHX: Law Offices of Howard G. Smith Reminds Shareholders of Opportunity to Lead Securities Fraud Class Actions - aTyr Pharma ( NASDAQ:ATYR ) , Baxter Intl ( NYSE:BAX )
BENSALEM, Pa., Nov. 13, 2025 ( GLOBE NEWSWIRE ) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.
ATYR Investors: Securities Law Firm Robbins LLP Reminds Investors of the Pending Lead Plaintiff Deadline in the Class Action Against aTyr Pharma, Inc. - aTyr Pharma ( NASDAQ:ATYR )
SAN DIEGO, Nov. 12, 2025 ( GLOBE NEWSWIRE ) -- Company: aTyr Pharma, Inc. ( NASDAQ:ATYR ) is a clinical stage biotechnology company leveraging evolutionary intelligence to translate tRNA synthetase biology into new therapies for fibrosis and inflammation.
ATYR Investor Alert: New aTyr Pharma, Inc. ( ATYR ) Securities Class Filed; Class Period Significantly Enlarged -- Hagens Berman - aTyr Pharma ( NASDAQ:ATYR )
SAN FRANCISCO, Nov. 12, 2025 ( GLOBE NEWSWIRE ) -- A new class action complaint has been filed against aTyr Pharma, Inc. ( NASDAQ:ATYR ) and certain of its top executives, significantly enlarging the alleged class period covered by the ongoing securities litigation.
ATYR Investor Alert: New aTyr Pharma, Inc. ( ATYR ) Securities Class Filed; Class Period Significantly Enlarged - Hagens Berman - aTyr Pharma ( NASDAQ:ATYR )
SAN FRANCISCO, Nov. 10, 2025 ( GLOBE NEWSWIRE ) -- A new class action complaint has been filed against aTyr Pharma, Inc. ( NASDAQ:ATYR ) and certain of its top executives, significantly enlarging the alleged class period covered by the ongoing securities litigation.
aTyr Pharma to Present at Piper Sandler 37th Annual Healthcare Conference - aTyr Pharma ( NASDAQ:ATYR )
SAN DIEGO, Nov. 10, 2025 ( GLOBE NEWSWIRE ) -- aTyr Pharma, Inc. ( NASDAQ:ATYR ) , a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced that Sanjay S.
ATYR SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that aTyr Pharma Investors Have Opportunity to Lead Class Action Lawsuit - aTyr Pharma ( NASDAQ:ATYR )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses In aTyr To Contact Him Directly To Discuss Their Options
ROSEN, HIGHLY RANKED INVESTOR COUNSEL, Encourages aTyr Pharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATYR - aTyr Pharma ( NASDAQ:ATYR )
NEW YORK, Nov. 08, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of aTyr Pharma, Inc. ( NASDAQ:ATYR ) between January 16, 2025 and September 12, 2025, both dates inclusive ( the "Class Period" ) , of the important ...
ATYR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that aTyr Pharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - aTyr Pharma ( NASDAQ:ATYR )
NEW YORK, Nov. 07, 2025 ( GLOBE NEWSWIRE ) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against aTyr Pharma, Inc. ( "aTyr" or "the Company" ) ( NASDAQ:ATYR ) and certain of its ...
Shareholders that lost money on aTyr Pharma, Inc. ( ATYR ) should contact Levi & Korsinsky about pending Class Action - ATYR - aTyr Pharma ( NASDAQ:ATYR )
NEW YORK, Nov. 06, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in aTyr Pharma, Inc. ( "aTyr" or the "Company" ) ( NASDAQ:ATYR ) of a class action securities lawsuit.
DEADLINE ALERT for MRX, ATYR, and WPP: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - aTyr Pharma ( NASDAQ:ATYR ) , Marex Group ( NASDAQ:MRX )
LOS ANGELES, Nov. 06, 2025 ( GLOBE NEWSWIRE ) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.
DEADLINE ALERT for ATYR, MLTX, BAX, JHX: Law Offices of Howard G. Smith Reminds Shareholders of Opportunity to Lead Securities Fraud Class Actions - aTyr Pharma ( NASDAQ:ATYR ) , Baxter Intl ( NYSE:BAX )
BENSALEM, Pa., Nov. 06, 2025 ( GLOBE NEWSWIRE ) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.
Investors in aTyr Pharma, Inc. ( ATYR ) : Protect Your Rights - Contact Levi & Korsinsky Before December 8, 2025
Investors in aTyr Pharma, Inc. (ATYR): Protect Your Rights - Contact Levi & Korsinsky Before December ...
The Gross Law Firm Reminds aTyr Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 8, 2025 - ATYR - aTyr Pharma ( NASDAQ:ATYR )
NEW YORK, Nov. 05, 2025 ( GLOBE NEWSWIRE ) -- The Gross Law Firm issues the following notice to shareholders of aTyr Pharma, Inc. ( NASDAQ:ATYR ) . Shareholders who purchased shares of ATYR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff ...
Deadline Alert: aTyr Pharma Inc. ( ATYR ) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - aTyr Pharma ( NASDAQ:ATYR )
LOS ANGELES, Nov. 04, 2025 ( GLOBE NEWSWIRE ) -- Glancy Prongay & Murray LLP reminds investors of the upcoming December 8, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired aTyr Pharma Inc. ( "aTyr" or the "Company" ...
aTyr Pharma, Inc. ( ATYR ) Failed Drug Trial Spurs Securities Lawsuit; Class Period Significantly Enlarged -- Hagens Berman - aTyr Pharma ( NASDAQ:ATYR )
SAN FRANCISCO, Nov. 03, 2025 ( GLOBE NEWSWIRE ) -- A new class action complaint has been filed against aTyr Pharma, Inc. ( NASDAQ:ATYR ) and certain of its top executives, significantly enlarging the alleged class period covered by the ongoing securities litigation.
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of aTyr Pharma, Inc. ( ATYR ) Investors - Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm - aTyr Pharma ( NASDAQ:ATYR )
ATLANTA, Nov. 03, 2025 ( GLOBE NEWSWIRE ) -- A shareholder class action lawsuit has been filed against aTyr Pharma, Inc. ( "aTyr" or the "Company" ) ( NASDAQ:ATYR ) .
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages aTyr Pharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATYR - aTyr Pharma ( NASDAQ:ATYR )
NEW YORK, Nov. 02, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of aTyr Pharma, Inc. ( NASDAQ:ATYR ) between January 16, 2025 and September 12, 2025, both dates inclusive ( the "Class Period" ) , of the important ...
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ...
ATYR Shareholder Alert: New aTyr Pharma, Inc. ( ATYR ) Securities Class Filed; Class Period Significantly Enlarged -- Hagens Berman - aTyr Pharma ( NASDAQ:ATYR )
SAN FRANCISCO, Oct. 31, 2025 ( GLOBE NEWSWIRE ) -- A new class action complaint has been filed against aTyr Pharma, Inc. ( NASDAQ:ATYR ) and certain of its top executives, significantly enlarging the alleged class period covered by the ongoing securities litigation.
DEADLINE ALERT for ATYR, MLTX, BAX: Law Offices of Howard G. Smith Reminds Shareholders of Opportunity to Lead Securities Fraud Class Actions - aTyr Pharma ( NASDAQ:ATYR ) , Baxter Intl ( NYSE:BAX )
BENSALEM, Pa., Oct. 31, 2025 ( GLOBE NEWSWIRE ) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.
ATYR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that aTyr Pharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - aTyr Pharma ( NASDAQ:ATYR )
NEW YORK, Oct. 31, 2025 ( GLOBE NEWSWIRE ) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against aTyr Pharma, Inc. ( "aTyr" or "the Company" ) ( NASDAQ:ATYR ) and certain of its ...
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ...
The Gross Law Firm Notifies aTyr Pharma, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ATYR - aTyr Pharma ( NASDAQ:ATYR )
NEW YORK, Oct. 30, 2025 ( GLOBE NEWSWIRE ) -- The Gross Law Firm issues the following notice to shareholders of aTyr Pharma, Inc. ( NASDAQ:ATYR ) . Shareholders who purchased shares of ATYR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff ...
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma - aTyr Pharma ( NASDAQ:ATYR )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses In aTyr To Contact Him Directly To Discuss Their Options
aTyr Pharma, Inc. ( ATYR ) Securities Class Action Filed; Class Period Significantly Enlarged -- Hagens Berman - aTyr Pharma ( NASDAQ:ATYR )
SAN FRANCISCO, Oct. 29, 2025 ( GLOBE NEWSWIRE ) -- A new class action complaint has been filed against aTyr Pharma, Inc. ( NASDAQ:ATYR ) and certain of its top executives, significantly enlarging the alleged class period covered by the ongoing securities litigation.
Investors who lost money on aTyr Pharma, Inc. ( ATYR ) should contact Levi & Korsinsky about pending Class Action - ATYR - aTyr Pharma ( NASDAQ:ATYR )
NEW YORK, Oct. 28, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in aTyr Pharma, Inc. ( "aTyr" or the "Company" ) ( NASDAQ:ATYR ) of a class action securities lawsuit.
ROSEN, LEADING INVESTOR COUNSEL, Encourages aTyr Pharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATYR - aTyr Pharma ( NASDAQ:ATYR )
NEW YORK, Oct. 27, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of aTyr Pharma, Inc. ( NASDAQ:ATYR ) between January 16, 2025 and September 12, 2025, both dates inclusive ( the "Class Period" ) , of the important ...
ATYR Investor Alert: New aTyr Pharma, Inc. ( ATYR ) Securities Class Filed; Class Period Significantly Enlarged -- Hagens Berman - aTyr Pharma ( NASDAQ:ATYR )
SAN FRANCISCO, Oct. 27, 2025 ( GLOBE NEWSWIRE ) -- A new class action complaint has been filed against aTyr Pharma, Inc. ( NASDAQ:ATYR ) and certain of its top executives, significantly enlarging the alleged class period covered by the ongoing securities litigation.
Deadline Alert: aTyr Pharma Inc. ( ATYR ) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - aTyr Pharma ( NASDAQ:ATYR )
LOS ANGELES, Oct. 27, 2025 ( GLOBE NEWSWIRE ) -- Glancy Prongay & Murray LLP reminds investors of the upcoming December 8, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired aTyr Pharma Inc. ( "aTyr" or the "Company" ...
ATYR SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma - aTyr Pharma ( NASDAQ:ATYR )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses In aTyr To Contact Him Directly To Discuss Their Options
DEADLINE ALERT for MRX, ATYR, and WPP: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - aTyr Pharma ( NASDAQ:ATYR ) , Marex Group ( NASDAQ:MRX )
LOS ANGELES, Oct. 24, 2025 ( GLOBE NEWSWIRE ) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.
Levi & Korsinsky Notifies aTyr Pharma, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ATYR
Levi & Korsinsky Notifies aTyr Pharma, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline ...
Bragar Eagel & Squire, P.C. Reminds Investors of aTyr, Marex, Cepton, and MoonLake to Contact the Firm About their Rights in Filed Class Action Lawsuits - aTyr Pharma ( NASDAQ:ATYR )
NEW YORK, Oct. 22, 2025 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of aTyr Pharma, Inc. ( NASDAQ:ATYR ) , Marex Group PLC ( NASDAQ:MRX ) , Cepton, Inc. ...
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of aTyr Pharma, Inc. ( ATYR ) Shareholders - aTyr Pharma ( NASDAQ:ATYR )
NEW YORK, Oct. 22, 2025 ( GLOBE NEWSWIRE ) -- The Gross Law Firm issues the following notice to shareholders of aTyr Pharma, Inc. ( NASDAQ:ATYR ) . Shareholders who purchased shares of ATYR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff ...
ROSEN, A LONGSTANDING LAW FIRM, Encourages aTyr Pharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATYR - aTyr Pharma ( NASDAQ:ATYR )
NEW YORK, Oct. 21, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of aTyr Pharma, Inc. ( NASDAQ:ATYR ) between January 16, 2025 and September 12, 2025, both dates inclusive ( the "Class Period" ) , of the important ...
ATYR SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ATyr Pharma
ATYR SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ...
aTyr Pharma, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - ATYR - aTyr Pharma ( NASDAQ:ATYR )
NEW YORK, Oct. 17, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in aTyr Pharma, Inc. ( "aTyr" or the "Company" ) ( NASDAQ:ATYR ) of a class action securities lawsuit.
Faruqi & Faruqi Reminds ATyr Pharma Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 9, 2025 - ATYR - aTyr Pharma ( NASDAQ:ATYR )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses In ATyr To Contact Him Directly To Discuss Their Options
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages aTyr Pharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATYR - aTyr Pharma ( NASDAQ:ATYR )
NEW YORK, Oct. 15, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of aTyr Pharma, Inc. ( NASDAQ:ATYR ) between January 16, 2025 and September 12, 2025, both dates ...
ATYR ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against aTyr Pharma, Inc. and Encourages Investors to Contact the Firm - aTyr Pharma ( NASDAQ:ATYR )
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In aTyr ( ATYR ) To Contact Him Directly To Discuss Their Options Click here to participate in the action. NEW YORK, Oct. 14, 2025 ( GLOBE NEWSWIRE ) --
aTyr Pharma, Inc.'s ( ATYR ) Failed Drug Trial Spurs Securities Lawsuit -- Hagens Berman - aTyr Pharma ( NASDAQ:ATYR )
SAN FRANCISCO, Oct. 13, 2025 ( GLOBE NEWSWIRE ) -- A federal class-action lawsuit has been filed against aTyr Pharma, Inc. ( NASDAQ:ATYR ) following a devastating 83% drop in the biotech company's stock price after its lead drug candidate failed to meet its primary endpoint in a critical Phase 3 ...
This Stock Is Up By 285% This Year But Could Still Jump By 53%, According to Wall Street
Is it too late to get on the bandwagon?
ATYR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that aTyr Pharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - aTyr Pharma ( NASDAQ:ATYR )
NEW YORK, Oct. 12, 2025 ( GLOBE NEWSWIRE ) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against aTyr Pharma, Inc. ( "aTyr" or "the Company" ) ( NASDAQ:ATYR ) and certain of its ...
